Manufacturer copay assistance · Zynlonta (J9359) · ADC Therapeutics
$0/dose · Maximum benefit Up to $25,000 per calendar year · Covers Zynlonta drug cost only — does not cover administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Zynlonta — the program's cap applies against the patient share CareCost calculates.
Yes — ADVANCING Patient Support Co-Pay Program from ADC Therapeutics. Eligible patients may pay $0 copay. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay $0 copay Maximum benefit: Up to $25,000 per calendar year. Covers Zynlonta drug cost only — does not cover administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.